olsalazine
(ZJEFYLVGGFISGT-UHFFFAOYSA-L)
Structure
- SMILES
- OC(=O)c1cc(N=Nc2ccc(c(c2)C(=O)O)[O-])ccc1[O-].[Na+].[Na+]
- Molecular Formula:
- C14H8N2Na2O6
- Molecular Weight:
- 346.203
- Log P:
- 3.7860
- Hydrogen Bond Acceptor:
- 8
- Hydrogen Bond Donor:
- 2
- TPSA:
- 145.44
- CAS Number(s):
- 6054-98-4
Synonym(s)
1.
olsalazine
2.
CJ-91B
3.
Dipentum
4.
Rasal
5.
azodisal sodium
6.
azodisalicylate
7.
disodium 5,5'-azodisalicylate
8.
disodium azodisalicylate
9.
olsalazine sodium
10.
olsalazine, disodium salt
11.
sodium diazosalicylate
External Link(s)
| MeSH | C032587 |
| PubChem Compound | 136663924 135413505 |
| ChEBI | 63614 |
| CHEMBL | CHEMBL3187425 CHEMBL1201013 |
| KEGG | dr:D00727 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Pancreatitis | FAERS: 3 | US FAERS | |
| 2 | Drug exposure during pregnancy | FAERS: 2 | US FAERS | |
| 3 | Alanine Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 4 | Anxiety | FAERS: 1 | US FAERS | |
| 5 | Aspartate Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 6 | Atrioventricular Block | FAERS: 1 | US FAERS | |
| 7 | Colitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Complications of maternal exposure to therapeutic drugs | FAERS: 1 | US FAERS | |
| 9 | Crying | FAERS: 1 | US FAERS | |
| 10 | Disease recurrence | FAERS: 1 | US FAERS | |
| 11 | Drug exposure via breast milk | FAERS: 1 | US FAERS | |
| 12 | Fatigue | FAERS: 1 | US FAERS | |
| 13 | Iatrogenic injury | FAERS: 1 | US FAERS | |
| 14 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 15 | Mental impairment | FAERS: 1 | US FAERS | |
| 16 | Neutrophil count decreased | FAERS: 1 | US FAERS | |
| 17 | Pain | FAERS: 1 | US FAERS | |
| 18 | Poor weight gain neonatal | FAERS: 1 | US FAERS | |
| 19 | Post procedural complication | FAERS: 1 | US FAERS | |
| 20 | Restlessness | FAERS: 1 | US FAERS | |
| 21 | Transaminases increased | FAERS: 1 | US FAERS | |
| 22 | Tremor | FAERS: 1 | US FAERS | |
| 23 | White blood cell count decreased | FAERS: 1 | US FAERS | |
| 24 | Wrong technique in drug usage process | FAERS: 1 | US FAERS | |
| 25 | nervous system disorder | FAERS: 1 | US FAERS | |
| 26 | Thrombocytopenia | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.